CLLS
Cellectis

2,595
Mkt Cap
$282.07M
Volume
10,398.00
52W High
$5.48
52W Low
$1.10
PE Ratio
-11.69
CLLS Fundamentals
Price
$3.90
Prev Close
$3.99
Open
$3.96
50D MA
$4.24
Beta
1.06
Avg. Volume
45,092.80
EPS (Annual)
-$0.4052
P/B
3.89
Rev/Employee
$186,629.20
$12.36
Loading...
Loading...

About

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
222

Frequently Asked Questions

What is Market Cap of Cellectis - ADR?
What is the 52-week high for Cellectis - ADR?
What is the 52-week low for Cellectis - ADR?
What is Cellectis - ADR stock price today?
What was Cellectis - ADR stock price yesterday?
What is the PE ratio of Cellectis - ADR?
What is the Price-to-Book ratio of Cellectis - ADR?
What is the 50-day moving average of Cellectis - ADR?
How many employees does Cellectis - ADR have?

Latest CLLS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.